US: CHME - China Medicine Corporation

Yield per half year: 0%
Dividend yield: 0.00%

Share chart China Medicine Corporation


About China Medicine Corporation

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.

more details
; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.cmc621.com/cmc/index.php
Цена ао 0.0001
Change price per day: 0% (0.0001)
Change price per week: 0% (0.0001)
Change price per month: 0% (0.0001)
Change price per 3 month: 0% (0.0001)
Change price per half year: 0% (0.0001)
Change price per year: 0% (0.0001)
Change price per 3 year: -50% (0.0002)
Change price per 5 year: -99.88% (0.08)
Change price per year to date: -96.67% (0.003)

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 1.43

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 522.59 10
Yield Ebitda, % -63462.78 0
Yield EPS, % -122.79 0
Total: 2

Head Job title Payment Year of birth
Mr. Senshan Yang Chairman, CEO & Chairman of Guangzhou Konzern Medicine Co., Ltd 1961 (64 years)
Mr. Ho Chi Fung Chief Financial Officer 1972 (53 years)
Ms. Huizhen Yu Controller 1980 (45 years)

Address: China, Guangzhou, 2/F Guangri Tower - open in Google maps, open in Yandex maps
Website: https://www.cmc621.com/cmc/index.php